IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations

03/04/2026 | Press release | Distributed by Public on 03/04/2026 08:21

Artificial intelligence in pharmaceutical manufacturing – navigating innovation and regulation

Artificial Intelligence (AI) and Machine Learning (ML) are rapidly transforming various sectors, and the pharmaceutical manufacturing industry is no exception.

This paper explores how the pharmaceutical industry may use individual applications of AI in pharmaceutical manufacturing and control. It describes the evolving regulatory landscape and provides key considerations for national regulatory authorities (NRA) when reviewing regulatory submissions or inspecting manufacturing sites that use or describe AI technologies in their processes.

IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations published this content on March 04, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on March 04, 2026 at 14:21 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]